DeviceTalks Podcast Network

In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead.

Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com.

At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies
(00:06:10) - This is not your Father’s TAVR
(00:08:00) - Terms of the Medtronic investment
(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical
(00:29:50) - How is minimally invasive technology changing?
(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular
(00:35:30) - What makes a good neurosurgeon?
(00:39:01) - Choosing impact over intimacy
(00:44:50) - What do patients fear more than death?
(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next.

In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit www.averna.com to learn more.

We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies.

To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup
(00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter
(00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4
(00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall
(00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies
(00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna
(00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health.

In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success.

Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand.

MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs
(00:06:43) - Edwards gives up on $1.2B JenaValve acquisition
(00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
(00:11:12) - Medtronic has ‘significant firepower’ to boost M&A
(00:13:08) - All the big news from Boston Scientific
(00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical
(00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics

Innovation doesn’t happen by accident. It happens when leaders intentionally design the systems that allow curiosity, experimentation, and good ideas to survive.

In this episode of the Women in MedTech podcast, host Kayleen Brown sits down with Dr. Rebecca Gottlieb, VP of Advanced Sensor Technologies at Biolinq, to explore what it really takes to build innovation engines inside regulated MedTech environments. From early clinical work with artificial heart patients, to more than two decades of sensor innovation at Medtronic, to leading advanced biosensing platforms at Biolinq, Rebecca explains why curiosity isn’t just a mindset — it’s a leadership strategy.

Kayleen also welcomes Chris Dawson, Head of Biosensing at TTP PLC, to unpack what curiosity looks like in practice: how multidisciplinary teams explore what’s possible, retire risk early, and build systems that support innovation without compromising reliability or regulatory rigor. Thank you to TTP for your support, to learn more visit: https://www.ttp.com.

Before you go, make sure to download your complimentary e-books from TTP today! 

Rethinking Regulatory Compliance -  How to turn regulatory demands in MedTech into development strengths

Optimising Bluetooth Connectivity in Implantable Medical Devices

Automated Biosensor Testing for the Development of Continuous Health Monitors

***

Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players:
https://women-in-medtech.castos.com/subscribe

Follow us on YouTube:
https://www.youtube.com/@DeviceTalks

Want access to the complete DeviceTalks Podcast Network (DTPN)?
Follow us at https://devicetalks.castos.com/subscribe

Chapters

(00:00:00) - Why innovation systems matter in MedTech
(00:00:01) - Introducing in-studio guest, Chris Dawson, TTP
(00:00:02) - What innovation looks like inside multidisciplinary teams
(00:00:03) - Start of keynote interview with Rebecca Gottlieb, Biolinq
(00:00:04) - From startup to Medtronic: scaling innovation across environments
(00:00:05) - Internal venture programs: designing systems for ideas to surface
(00:00:06) - Leadership as barrier removal, not control
(00:00:07) - Why Rebecca chose Biolinq: platforms, microneedles, and possibility
(00:00:08) - Rethinking glucose monitoring for Type 2 diabetes
(00:00:09) - FDA De Novo clearance and sustaining teams through long timelines
(00:00:10) - The future of biosensing: DNA-based receptors and new analytes
(00:00:11) - Leadership reflections and closing: curiosity as an innovation engine

HAPPY NEW YEAR! Host Tom Salemi squeezes in that salutation one final time in our first episode of DeviceTalks Weekly.

In this episode, Managing Editor Kayleen Brown shines the FOMO spotlight on a possible new approach to treating stroke victims. Liane Teplitsky, now executive chair of Executive Chair of the Board of Directors of Carvolix, explains how an early-stage robot could give more interventionalists the power to help stroke victims.

Tom Salemi and MassDevice’s Chris Newmarker Vensana Capital Co-founder Justin Klein, MD, as a temporary member of the Newsmaker team where the review the highs and lows of the first full week of the year. Tom and Justin then talk about the state of MedTech venture capital starting with the HSBC annual report.

Finally, Chris Newmarker hosts our keynote interview featuring Lisa Anderson, president of Paragonix Technologies, which is upending how donated organs are stored for transportation before transplantation.

Newsmakers include the late Tom Fogarty, Teleflex, Staar Surgical, Alcon, W.L. Gore, Conformal, and Johnson & Johnson MedTech.

You can access the HSBC report here - https://www.hsbcinnovationbanking.com/us/en/resources/2025-annual-venture-healthcare-report?cid=B:OSOC:10937621680:10893300135

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:40) - Meet Justin Klein, MD, co-founder managing partner, Vensana Capital
(00:08:42) - MedTech pioneer Dr. Tom Fogarty passes away at 91
(00:14:28) - Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance
(00:17:20) - Staar Surgical to terminate Alcon deal after stockholder vote W.L. Gore to acquire left atrial appendage device maker Conformal Medical
(00:20:10) - W.L. Gore to acquire left atrial appendage device maker Conformal Medical
(00:24:45) - Johnson & Johnson MedTech submits Ottava surgical robot to FDA
(00:27:19) - Tom and Justin review HSCB report
(00:46:54) - FOMO Interview with Kayleen Brown and Liane Teplitsky
(00:57:38) - Keynote interview with Lisa Anderson, President, Paragonix Technologies